Close
Adolfo Diaz Duque, M.D.
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Adolfo Diaz Duque, M.D.
Dr. Enrique Diaz is a faculty member in the Division of Hematology-Oncology. He completed his medical training with honors at the Pontificia Universidad Javeriana (Colombia) and his Internal Medicine residency at New York University. He completed his Fellowship in Hematology-Oncology and also received a Master of Science in Clinical Investigation and Translational Science degree, both from University of Texas Health Science Center San Antonio. His research and clinical interests focus on improving outcomes in patients with lymphomas and also on health care disparities. He currently serves as Ambassador for the American Society of Hematology.
Gender
- Male
Languages Spoken
- Spanish
-
Credentials
Credentials
Certifications
- American Board of Internal Medicine/Hematology
- American Board of Internal Medicine
Education
- Medical School: Pontificia Universidad Javeriana
- Residency: Woodhull Medical and Mental Health Center
- Fellowship: University of Texas Health Science Center
-
Locations & Contact
Locations & Contact
I really appreciate that every time I visit Dr. Diaz he knows my circumstances and has a plan for me.
Patient
-
Research & Publications
Research & Publications
No Research & Publications
-
Clinical Trials
Clinical Trials
Type of Cancer
Multiple Sites
ClinicalTrials.gov Identifier
NCT02834013
Principal Investigator
Adolfo Diaz Duque M.D.
S1609: Dart: Dual Anti-CTLA-4 and Anti-PD-1 Blockage in Rare Tumors (CTMS# 17-0013)
Type of Cancer
Other Hematopoietic
ClinicalTrials.gov Identifier
NCT02736357
Principal Investigator
Adolfo Diaz Duque M.D.
LS0386, Clinical and Epidemiological Studies in Lymphoma (CTMS#18-0162)
The goal of this infrastructure grant is to establish and maintain a cohort of over 12,000 non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research that identifies clinical (including co-morbid diseases), epidemiologic (including lifestyle and other exposures), host genetic, tumor, and treatment factors, as well as the interaction among these factors, on short and long-term…